Willkommen, schön sind Sie da!
Logo Ex Libris

Tumor Biomarker Discovery: Methods and Protocols

  • Fester Einband
  • 332 Seiten
(0) Erste Bewertung abgeben
Alle Bewertungen ansehen
Cancer cells provide biomarker material that can lead to their own detection. This text on biomarker technologies covers a range o... Weiterlesen
196.00 CHF 156.80
Sie sparen CHF 39.20
Auslieferung erfolgt in der Regel innert 2 bis 4 Werktagen.
Bestellung & Lieferung in eine Filiale möglich


Cancer cells provide biomarker material that can lead to their own detection. This text on biomarker technologies covers a range of biomarker assay formats and systems as well as pitfalls of biomarker discovery and validation technologies.

Biomarkers are molecular indicators of a biological status and, as biochemical species, can be interrogated to evaluate disease status and therapeutic interventions. Biomarkers may be detectable in the blood, other body fluids, or tissues. The expectation is that the level of an informative biomarker is related to the specific type of disease present in the body. Hence, disease-relevant biomarkers can be used to measure the presence, progress, or intensity of disease. Through a variety of mechanisms, cancer cells provide the biomarker material for their own detection. Tumor biomarkers include cancer-specific mutations or changes in gene expression, both of which can result in aberrant protein expression. These variant or abundant proteins can be detectable in the circulation as the free proteins or as novel autoantibodies to those proteins, the latter indicating that the immune system can provide an exquisitely sensitive sensor of disease. Because cancer cells shed DNA in the circu- tion, an event rarely seen in healthy individuals, tumor-specific genetic changes, such as promoter methylation or gene mutations, are detectable in DNA prepared from plasma or other body fluids. Cancer-related biochemical changes often effect measurable me- bolic variations within a cell or organism. In addition, these biochemical changes result in posttranslational modification of proteins via glycosylation or phosphorylation providing a plethora of opportunity for biomarker discovery.

Provides a detailed overview of the range of biomarker technologies as written by leading researchers in the field

Useful both for researchers interested in new tumor biomarkers and physicians seeking familiarity with new technologies in the clinical setting

Covers a wide range of biomarker assay formats and systems

Presents alternative approaches to similar forms of biomarkers, covering a variety of detection technologies and approaches to data analysis

Comprehensive guide to pitfalls of biomarker discovery and validation technologies


Through a variety of mechanisms, cancer cells provide the biomarker material that can lead to their own detection, which then grants clinicians the opportunity for non-invasive body fluid and tissue analysis able to indicate the presence of tumors or the level of tumor burden.  In Tumor Biomarker Discovery: Methods and Protocols, experts in the field present detailed chapters focused on the use and development of panels of biomarker analytes while covering subjects such as nucleic acids and protein-based technologies, metabolic profiling by analytic means or spectroscopy, as well as study designs for biomarker discovery and validation. Written in the highly successful Methods in Molecular Biology™ series format, chapters include brief introductions to the topics, lists of the necessary materials or reagents, step-by-step laboratory protocols, and notes on troubleshooting and avoiding known pitfalls.

Cutting-edge and authoritative, Tumor Biomarker Discovery: Methods and Protocols is an ideal guide to the technologies that can be used to discover and validate tumor biomarker panels suitable for the presymptomatic early detection of cancer.

1. Identification of Tumor-Associated Antigens (TAAs) as Diagnostic and Predictive Biomarkers in Cancer Jian-Ying Zhang, Kok Sun Looi, and Eng M. Tan 2. Autoantibodies against Cancer Antigens Sacha Gnjatic, Lloyd J. Old, and Yao-Tseng Chen 3. Discovery of Antibody Biomarkers Using Protein Microarrays of Tumor Antigens Cloned in High-Throughput Madhumita Chatterjee, Jerzy Wojciechowski, and Michael A. Tainsky 4. Analysis of Glycans on Serum Proteins Using Antibody Microarrays Songming Chen and Brian B. Haab 5. Glycoproteomic Analysis by Two Dimensional Electrophoresis Mary Ann Comunale and Anand Mehta 6. All-Liquid Separations, Protein Microarrays and Mass Spectrometry to Interrogate Serum Proteomes: An Application to Serum Glycoproteomics Tasneem H. Patwa, Yinghua Qiu, Jia Zhao, Diane M. Simeone, and David M. Lubman 7. Reverse Phase Protein Microarrays for Theranostics and Patient Tailored Therapy Virginia Espina, Lance A. Liotta, and Emanuel F. Petricoin III 8. Serum Proteomics Using Mass Spectrometry Brian L. Hood, David E. Malehorn, Thomas P. Conrads, and William L. Bigbee 9. Hormones as Biomarkers: Practical Guide to Utilizing Luminex Technolgies for Biomarker Research Faina Linkov, Zoya Yurkovetsky, and Anna Lokshin 10. High-Throughput Analysis of Serum Antigens Using Sandwich ELISAs on Microarrays Shannon L. Servoss, Rachel Gonzalez, Susan Varnum, and Richard C. Zangar 11. Tissue Microarrays as a Tool in the Discovery and Validation of Tumor Markers Stephen M. Hewitt 12. Quantitative, Fluorescence-Based In-Situ Assessment of Protein Expression Christopher B. Moeder, Jennifer M. Giltnane, Sharon Pozner Moulis, and David L. Rimm 13. Tumor Marker Discovery by Expression Profiling RNA from Formalin Fixed Paraffin Embedded Tissues Maureen T. Cronin, Debjani Dutta, Mylan Pho, Anhthu Nugyen, Jennie Jeong, and Mei-Lan Liu 14. High-Throughput Mutation Screening Using a Single Amplification Condition Lijia Shi and John E. Landers 15. DNA Sequencing of Cancer-Related Genes for Biomarker Discovery Lisa M. Farwell and Victoria A. Joshi 16. Analysis of Loss of Heterozygosity in Circulating DNA Takeshi Nakamura, Eiji Sunami, and Dave S. B. Hoon 17. Pharmacogenomics Shilong Zhong and Marjorie Romkes 18. Study Designs in Genetic Epidemiology Michele L. Cote 19. Developing Classifiers for the Detection of Cancer Using Multi-Analytes Adi Laurentiu Tarca, Sorin Draghici, and Roberto Romero 20. Metabolomics of Cancer Natalie J. Serkova and Kristine Glunde 21. MRI and MRS of Human Brain Tumors Bob L. Hou and Jiani Hu 22. Magnetic Resonance Spectroscopy of Living Tissues Natalie J. Serkova, Kendra M. Hasebroock, and Susan L. Kraft


Titel: Tumor Biomarker Discovery: Methods and Protocols
Untertitel: Methods and Protocols
EAN: 9781603278102
ISBN: 1603278109
Format: Fester Einband
Genre: Medizin
Veröffentlichung: 01.04.2009
Anzahl Seiten: 332
Gewicht: 892g
Größe: H270mm x B200mm x T25mm
Jahr: 2009
Untertitel: Englisch
Auflage: 2009

Weitere Produkte aus der Reihe "Methods in Molecular Biology"